Tyra Biosciences, Inc. (TYRA) Operating cash flow 2020–2025
Tyra Biosciences, Inc. (TYRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$95.1MFY2025 · since FY2020: -$7.8M → -$95.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$95.1M | -36.4% |
| FY2024 | -$69.8M | -39.2% |
| FY2023 | -$50.1M | +0.3% |
| FY2022 | -$50.3M | -111.8% |
| FY2021 | -$23.7M | -205.9% |
| FY2020 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice